Paramethadione
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
(RS)-5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione
|
|
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Pharmacokinetic data | |
Protein binding | Not significant |
Identifiers | |
CAS Number | 115-67-3 |
ATC code | N03AC01 (WHO) |
PubChem | CID: 8280 |
IUPHAR/BPS | 7261 |
DrugBank | DB00617 |
ChemSpider | 7979 |
UNII | Z615FRW64N |
KEGG | D00495 |
ChEMBL | CHEMBL1100 |
Chemical data | |
Formula | C7H11NO3 |
Molecular mass | 157.167 g/mol |
|
|
|
|
(verify) |
Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.[1]
Chemistry
Paramethadione, 5-ethyl-3,5-dimethyloxazolidine-2,4-dione, differs from trimethadione only in the substitution of one methyl group with an ethyl group. It is synthesized in a completely analogous manner, except that it comes from 2-hydroxy-2-methylbutyric acid instead of 2-hydroxyisobutyric acid.
- M.A. Spielman, U.S. Patent 2,575,693 (1951).
References
- ↑ Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes - Retrieved January 2007.
External links
- Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>